Fundraising Fox

The W Fund

Venture capital

Seattle Β· Pre-Seed–Series A

✨ Fox Verdict
Sign up to see your fit

Investment thesis

The W Fund supports early-stage technology companies emerging from Washington state's academic and research ecosystem. The fund prioritizes ventures based on intellectual property developed through university research programs and maintains strong connections to faculty and students at institutions including the University of Washington, Washington State University, and affiliated research centers. Investment focus spans life sciences, software, IT, engineering, and clean technology sectors, with typical first checks up to $500,000 in rounds of $1 million or more.

Source: firm website, verified Aug 7, 2026.

Stage
Pre-Seed–Series A
Check
$500K
HQ
Seattle, US
Leads rounds
Follows
Instruments
Equity
AUM
$20M
Tracked investments
18

What they invest in

from 9 of 18 portfolio companies

Biotech Γ—5Deep Tech Γ—4Hardware Γ—4Healthtech Γ—2Robotics Γ—2Advanced Manufacturing Γ—1AI & Machine Learning Γ—1Construction Tech Γ—1

HQs:United StatesΓ—10

Investments Β· 18 tracked

founders shown can be your intro path

By year:2018 Β· 12016 Β· 12015 Β· 13 dated

AnswerDashanswerdash.cominAug 2015

Seattle, US

JACOB O. WOBBROCK(Executive Officer)inWILLIAM T. COLLERAN(Executive Officer, Director)ANDREW KO(Executive Officer)

BoardWILLIAM MCALEER(Director)inMARK UPSON(Director)MICHAEL FRIDGEN(Director)

Co-investorsCowles VenturesVoyager CapitalWRF Capital

Aqueduct
Athira Pharma
Beat Biotherapeutics
Bellwether BioApr 2018

BiotechSeattle, US

Rahul Shendure(Executive Officer, Director, Promoter)Matthew Snyder(Director)

Co-investorsWRF Capital

Cardiac Insight Inc.cardiacinsightinc.comin𝕏

Cardiac Insight develops handheld and wearable ECG devices for cardiac diagnostics, including the Cardea 20/20 for athlete heart screening and the Cardea SOLO for 7-day ambulatory monitoring.

BiotechHardwareHealthtechMedical DevicesBellevue, US

David Linker(Executive Officer, Director)Dr. Dave Hadley(Founder)Dr. Vic Froelicher(Founder)Bill Willis(Executive Officer)inBrad Harlow(Executive Officer, Director)inRobert deGavre(Executive Officer, Director)

Co-investorsCowles VenturesKeiretsu ForumSeaChange

Csats

CSATS is a Seattle-based healthcare technology company providing AI-driven surgical video capture, analytics and performance feedback.

Seattle, US

Thomas Lendvay(Executive Officer, Director, Promoter)

BoardDerek Streat(Executive Officer, Director, Promoter)Hans Lundin(Director)

Co-investorsSPRINGROCK VENTURES

Cyrusbiocyrusbio.comin𝕏

Cyrus operates a protein engineering platform that combines AI and Rosetta computational design methods with a biochemistry lab performing large-scale deep mutagenesis scanning, protein stabilization, immunogenicity reduction, and affinity/specificity tuning.

AI & Machine LearningBiotechDeep TechSeattle, US

Yifan Song(CSO)inDavid Baker(Co-founder)Javier Castellanos(Executive Officer, Director)inMark(President & EVP, Business Development)

BoardLucas Nivon(CEO)

Co-investorsAnzu PartnersArgonautic VenturesiSelect FundOrbiMedSPRINGROCK VENTURESStrawberry Creek Ventures+2 more

HyperScienceshypersciences.comin𝕏

HyperSciences develops a hypersonic accelerator engine aimed at mining and tunneling applications.

Construction TechDeep TechHardwareSpokane, US

Mark Russell(Executive Officer, Director)inMichelle Carbon(Executive Officer)in

BoardMichael McSherry(Director)Charles Russell(Director)

Co-investorsCowles Ventures

Lumisands
NavisonicsAug 2016

BiotechHealthtechShoreline, US

Samuel R. Browd(Executive Officer, Director)Jens U. Quistgaard(Executive Officer, Director, Promoter)

BoardChris Igielski(Director)

Nexgenianexgeniacorp.com

Nexgenia develops proprietary stimuli-responsive polymer-based reagents for molecular and cellular selection, diagnostics, and immunoassays.

BiotechDeep TechNew MaterialsSeattle, US

Ron Myers(Executive Officer, Director)

BoardSteven Gillis(Director)Charles P. Waite(Director)Martin Simonetti(Director)Stewart Parker(Director)David Urdal(Director)

Co-investorsAlliance of AngelsWRF Capital

Olis Roboticsolisrobotics.comin

Olis Robotics provides remote monitoring, control, and troubleshooting solutions for industrial robots, serving over 50% of the global installed industrial robot fleet.

Advanced ManufacturingDeep TechEnterprise SoftwareRoboticsSeattle, US

Co-investorsAlliance of AngelsSeaChangeTectonic VenturesUbiquity Ventures

Past Companies
Stasys
Twinstrand
Vicisvicis.com𝕏

VICIS manufactures protective equipment for youth football players, specifically shoulder pads featuring advanced impact protection and lightweight design.

ConsumerHardwareSports Tech

WiBoticwibotic.comin𝕏

WiBotic makes wireless charging hardware and fleet energy management software for robots, drones, and autonomous vehicles, using adaptive antenna tuning to charge across different battery chemistries, voltages, and charging rates.

EnergyHardwareRoboticsSeattle, US

Benjamin Waters(Executive Officer, Director, Promoter)Joshua R Smith(Director)

BoardPingrong Yu(Director)Michael Li(Director)Robert Wetzel(Director)Mark Rogers(Director)

Co-investorsComet LabsWisemont CapitalTsing Capital

Portfolio news

latest coverage across their companies
WiBotic - The Infinite Unknown

WiBotic Β· jaredwatkins.com Β· Mar 31, 2026

Frequently asked questions

How many investments has The W Fund made?
The W Fund has 18 tracked investments.
What stage does The W Fund invest at?
The W Fund invests at the Pre-Seed, Seed, Series A stages.
What is The W Fund's typical check size?
The W Fund typically writes checks of $500K.
What sectors does The W Fund focus on?
The W Fund focuses on Biotech, Cleantech, Cloud Computing, Deep Tech, Hardware, Medical Devices, New Materials.
Where is The W Fund located?
The W Fund is headquartered in Seattle, US.
Does The W Fund lead rounds?
The W Fund typically participates in rounds rather than leading them.
Who does The W Fund co-invest with?
The W Fund most often shares deals with Cowles Ventures, SeaChange, SPRINGROCK VENTURES, among 16 tracked co-investors.

Similar investors

Featured in lists